191 related articles for article (PubMed ID: 33579350)
21. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP
Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399
[TBL] [Abstract][Full Text] [Related]
22. DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer.
Kawamura YI; Toyota M; Kawashima R; Hagiwara T; Suzuki H; Imai K; Shinomura Y; Tokino T; Kannagi R; Dohi T
Gastroenterology; 2008 Jul; 135(1):142-151.e3. PubMed ID: 18485915
[TBL] [Abstract][Full Text] [Related]
23. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
24. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells.
Mateen S; Raina K; Agarwal C; Chan D; Agarwal R
J Pharmacol Exp Ther; 2013 May; 345(2):206-14. PubMed ID: 23461975
[TBL] [Abstract][Full Text] [Related]
25. 5-Aza-2'-deoxycytidine advances the epithelial-mesenchymal transition of breast cancer cells by demethylating
Lu A; Wang W; Wang-Renault SF; Ring BZ; Tanaka Y; Weng J; Su L
J Cell Sci; 2020 May; 133(9):. PubMed ID: 32193333
[TBL] [Abstract][Full Text] [Related]
26. Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression.
Dudzik P; Trojan SE; Ostrowska B; Lasota M; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
Acta Biochim Pol; 2019 Dec; 66(4):619-625. PubMed ID: 31826047
[TBL] [Abstract][Full Text] [Related]
27. 5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene.
Chachadi VB; Cheng H; Klinkebiel D; Christman JK; Cheng PW
Int J Biochem Cell Biol; 2011 Apr; 43(4):586-93. PubMed ID: 21168523
[TBL] [Abstract][Full Text] [Related]
28. Treating cloned embryos, but not donor cells, with 5-aza-2'-deoxycytidine enhances the developmental competence of porcine cloned embryos.
Huan YJ; Zhu J; Xie BT; Wang JY; Liu SC; Zhou Y; Kong QR; He HB; Liu ZH
J Reprod Dev; 2013 Oct; 59(5):442-9. PubMed ID: 23748715
[TBL] [Abstract][Full Text] [Related]
29. Arsenic induces fibrogenic changes in human kidney epithelial cells potentially through epigenetic alterations in DNA methylation.
Chang YW; Singh KP
J Cell Physiol; 2019 Apr; 234(4):4713-4725. PubMed ID: 30191986
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
31. Morin exerts anti-metastatic, anti-proliferative and anti-adhesive effect in ovarian cancer cells: an in vitro studies.
Nowak E; Sypniewski D; Bednarek I
Mol Biol Rep; 2020 Mar; 47(3):1965-1978. PubMed ID: 32020427
[TBL] [Abstract][Full Text] [Related]
32. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH
Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066
[TBL] [Abstract][Full Text] [Related]
33. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.
Jung Y; Park J; Kim TY; Park JH; Jong HS; Im SA; Robertson KD; Bang YJ; Kim TY
J Mol Med (Berl); 2007 Oct; 85(10):1137-48. PubMed ID: 17571247
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
[TBL] [Abstract][Full Text] [Related]
35. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cells.
Tyagi T; Treas JN; Mahalingaiah PK; Singh KP
Breast Cancer Res Treat; 2015 Feb; 149(3):655-68. PubMed ID: 25663548
[TBL] [Abstract][Full Text] [Related]
37. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation.
Mossman D; Scott RJ
PLoS One; 2011; 6(8):e23127. PubMed ID: 21829702
[TBL] [Abstract][Full Text] [Related]
38. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
39. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.
Takeshima H; Wakabayashi M; Hattori N; Yamashita S; Ushijima T
Carcinogenesis; 2015 Feb; 36(2):192-201. PubMed ID: 25477340
[TBL] [Abstract][Full Text] [Related]
40. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
